Advertisement

Get Topic Updates

Share

Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team

medicalnewstoday.com

1 of 0

Resource Description:

Cytos Biotechnology AG announced that its vaccine candidate CYT002-NicQb to treat nicotine addiction hasachieved proof of efficacy. The phase II clinical trial results were presented by Prof. Dr.

« Back to the Smoking Cessation Injection WisdomCard

Related Health Centers:

Retrieved from "http://www.organizedwisdom.com/Special:OW_Special_Nugget"

Advertisement

Health Centers

Wellness Centers

Living Centers